Literature DB >> 15459946

Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs.

Naoki Nagahara1, Staffan Tavelin, Per Artursson.   

Abstract

The aim of this work was to investigate the contribution of the paracellular route to the pH-dependent permeability to cationic drugs in three models expressing different drug permeabilities: hexadecane membranes (HDMs), Caco-2, and 2/4/A1 cell monolayers. The high- and low-permeability drugs alfentanil and cimetidine were used as model drugs. The paracellular permeability was calculated: 1. from the assumption that the ionized form (P(mi)) permeates a cell monolayer only by the paracellular route, and 2. on basis of the pore-restricted diffusion. For both drugs, sigmoidal relationships between membrane permeability and pH were observed in all models. The P(mi) was in excellent agreement with the paracellular permeability of cimetidine in the two cell models, whereas no significant P(mi) of the drugs could be observed in HDM. The results showed that the paracellular route has a significant role in the permeability of small basic hydrophilic drugs, such as cimetidine in leaky, small intestinal-like epithelia such as 2/4/A1. By contrast, in tighter epithelia such as Caco-2 and in artificial membranes such as HDM, the permeability of the ionized forms of the drugs and the paracellular permeability are lower or insignificant, respectively. These findings will have implications in the experimental design and data interpretation of pH-dependent drug transport experiments in cell culture models as well as in artificial membrane models such as HDM and parallel artificial membrane permeability assay (PAMPA). (c) 2004 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15459946     DOI: 10.1002/jps.20206

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

2.  Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.

Authors:  David L Bourdet; Gary M Pollack; Dhiren R Thakker
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

3.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

Review 4.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

5.  Voltage dependence of transepithelial guanidine permeation across Caco-2 epithelia allows determination of the paracellular flux component.

Authors:  Georgina Carr; Iain S Haslam; Nicholas L Simmons
Journal:  Pharm Res       Date:  2006-03-10       Impact factor: 4.200

6.  Dynamic Protonation Dramatically Affects the Membrane Permeability of Drug-like Molecules.

Authors:  Zhi Yue; Chenghan Li; Gregory A Voth; Jessica M J Swanson
Journal:  J Am Chem Soc       Date:  2019-08-16       Impact factor: 15.419

7.  A new PAMPA model proposed on the basis of a synthetic phospholipid membrane.

Authors:  Hui Yu; Qi Wang; Ying Sun; Ming Shen; He Li; Yourong Duan
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

8.  Exploring tight junction alteration using double fluorescent probe combination of lanthanide complex with gold nanoclusters.

Authors:  Xinyi Wang; Na Wang; Lan Yuan; Na Li; Junxia Wang; Xiaoda Yang
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.